Evidence map›Paper›PMID 38665752›Full record

ReviewCureus2024

Artificial Intelligence-Powered Mammography: Navigating the Landscape of Deep Learning for Breast Cancer Detection.

Sahem Al Muhaisen, Omar Safi, Ahmad Ulayan, Sara Aljawamis, Maryam Fakhoury, Haneen Baydoun, Dua Abuquteish

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Advancements in oncology: Innovations in prevention and early detection.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sahem Al MuhaisenMedicine, Faculty of Medicine, The Hashemite University, Zarqa, JOR.
Omar SafiMedicine, Faculty of Medicine, The Hashemite University, Zarqa, JOR.
Ahmad UlayanMedicine, Faculty of Medicine, The Hashemite University, Zarqa, JOR.
Sara AljawamisMedicine, Faculty of Medicine, The Hashemite University, Zarqa, JOR.
Maryam FakhouryMedicine, Faculty of Medicine, The Hashemite University, Zarqa, JOR.
Haneen BaydounDiagnostic Radiology, King Hussein Cancer Center, Amman, JOR.
Dua AbuquteishMicrobiology, Pathology and Forensic Medicine, Faculty of Medicine, The Hashemite University, Zarqa, JOR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Worldwide, breast cancer (BC) is one of the most commonly diagnosed malignancies in women. Early detection is key to improving survival rates and health outcomes. This literature review focuses on how artificial intelligence (AI), especially deep learning (DL), can enhance the ability of mammography, a key tool in BC detection, to yield more accurate results. Artificial intelligence has shown promise in reducing diagnostic errors and increasing early cancer detection chances. Nevertheless, significant challenges exist, including the requirement for large amounts of high-quality data and concerns over data privacy. Despite these hurdles, AI and DL are advancing the field of radiology, offering better ways to diagnose, detect, and treat diseases. The U.S. Food and Drug Administration (FDA) has approved several AI diagnostic tools. Yet, the full potential of these technologies, especially for more advanced screening methods like digital breast tomosynthesis (DBT), depends on further clinical studies and the development of larger databases. In summary, this review highlights the exciting potential of AI in BC screening. It calls for more research and validation to fully employ the power of AI in clinical practice, ensuring that these technologies can help save lives by improving diagnosis accuracy and efficiency.

Indexed as

ai and machine learningartificial intelligencebreast cancercomputer-aided diagnosisdeep-learningmammographyscreening

Identifiers

PMID38665752
PMCPMC11044525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.